Although T2D patients had higher baseline FGF21 levels compared with healthy individuals, it appears that hyperinsulinemia or hepatic insulin resistance hampers the exercise-induced secretion of FGF21 [276]. The gene discussed is FGF21; the disease is hyperinsulinism.